The new tests could help detect malaria in cases where plasmodium parasites carry gene deletions impacting traditional rapid diagnostics.
NEW YORK – Lucid Diagnostics on Thursday announced that it had priced an underwritten registered direct offering of 18,000,000 common shares at a purchase price of $1.00 per share for total expected ...
ClearNote Health Advances Commercialization Prospects With Enhanced Pancreatic Cancer Detection Test
SAN DIEGO – With an enhanced version of its flagship pancreatic cancer assay now available and multiple studies underway for its multi-cancer early detection test, ClearNote Health is advancing its ...
The firm's collaborators presented research at AACR showing an association between ctDNA positivity and lack of pathologic ...
With the next PAMA data collection period starting in May, reporting by hospital labs in particular will be essential, but their level of participation remains uncertain.
The tests use AI-powered algorithms to analyze digital histopathology images, along with patient clinical data.
NEW YORK — Solvd Health said on Tuesday that it has received approval from the US Food and Drug Administration to offer its AvertD pharmacogenomic test for opioid use disorder (OUD) using blood ...
Top Five Articles on 360Dx Last Week: Roche $595M Acquisition; Labcorp, CHOP Pediatric Dx Deal; More
Last week, readers were most interested in a story about Roche expanding the cancer testing portfolio of subsidiary Foundation Medicine by buying Saga Diagnostics.
At AACR, Guardant Health and a Japanese group showcased data on machine learning models that predict the tissue of origin in cancers of unknown primary.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results